CPRIT grant helps recruit top DNA repair scientist
May 17, 2018
Dr. Sung’s discoveries have increased understanding of how DNA can repair damage induced by radiation, carcinogens and other causes.
Study: Gemcitabine helps prevent recurrence of low-grade bladder cancer
May 16, 2018
A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.
Audio spots focus on the how and why of what we do at UT Health San Antonio
May 7, 2018
To help increase awareness and preference for our organization, UT Health San Antonio has launched a highly visible ad campaign.
Trend shows later onset of dementia, fewer years of the disease
April 24, 2018
Findings could be related to reduced stroke risk.
Four trainees to present at American Association of Immunologists meeting
April 23, 2018
Four trainees in the Infection, Inflammation and Immunity (III) discipline of the Integrated Biomedical Sciences Ph.D. program and Department of Microbiology, Immunology and Molecular Genetics will make podium presentations in the upcoming American Association of Immunologists Annual Meeting in Austin, May 4-8. Read their stories
FDA panel recommends CBD medication for epilepsy
April 20, 2018
se E. Cavazos, M.D., Ph.D., professor of neurology and physiology at UT Health San Antonio and assistant dean of the institution’s M.D./Ph.D. program, reviewed clinical studies of the drug, which would be sold under the brand name Epidiolex.